Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects

NCT00706550 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

107

Enrollment

FED

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: (PV) 23-valent pneumococcal polysaccharide vaccine
BIOLOGICAL: Placebo

Sponsor

US Department of Veterans Affairs

Collaborators

[object Object]
[object Object]